Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

Collection: Health Policy and Services Research Series Title(s): Guidance for industry Contributor(s): United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. United States. Food and Drug Administration. Office of the Commissioner. Office of Special Medical Programs. Office of Combination Products, issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body. Center for Devices and Radiological Health (U.S.), issuing body. Publication: Silver Spring, MD : Center for Devices and Radiological Health, December 2017 Language(s): English Format: Text Subject(s): Autografts -- standards Biological Products -- standards Biological Products -- therapeutic use Tissue Transplantation -- standards Transplantation, Autologous Transplantation, Homologous Transplants -- standards United States United States. Department of Health and Human Services United States. Food and Drug Administration Genre(s): Guideline Technical Report Copyright: The National Library of Medicine believes this item to be in the public domain. (More information) Extent: 1 online resource (1 PDF file (24 pages)) Illustrations: Illustrations NLM Unique ID: 101719954 (See catalog record) Permanent Link: http://resource.nlm.nih.gov/101719954